Boston Scientific has updated the instructions for use for products deployed in the implantation of its Watchman heart device ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.